607 related articles for article (PubMed ID: 16125529)
41. [CLINICAL, BIOCHEMICAL AND HORMONAL PREDICTORS OF LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH ACROMEGALY].
Mykytyuk MR
Lik Sprava; 2015; (5-6):34-40. PubMed ID: 27089713
[TBL] [Abstract][Full Text] [Related]
42. Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study.
Colao A; Pivonello R; Grasso LF; Auriemma RS; Galdiero M; Savastano S; Lombardi G
Eur J Endocrinol; 2011 Nov; 165(5):713-21. PubMed ID: 21868601
[TBL] [Abstract][Full Text] [Related]
43. Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance.
Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Della Morte AM; Pivonello R; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 2001 Apr; 86(4):1551-7. PubMed ID: 11297582
[TBL] [Abstract][Full Text] [Related]
44. Surgical outcomes and predictors of glucose metabolism alterations for growth hormone-secreting pituitary adenomas: a hospital-based study of 151 cases.
He W; Yan L; Wang M; Li Q; He M; Ma Z; Ye Z; Zhang Q; Zhang Y; Qiao N; Lu Y; Ye H; Lu B; Shou X; Zhao Y; Li Y; Li S; Zhang Z; Shen M; Wang Y
Endocrine; 2019 Jan; 63(1):27-35. PubMed ID: 30238327
[TBL] [Abstract][Full Text] [Related]
45. Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly.
Jenkins PJ; Bates P; Carson MN; Stewart PM; Wass JA
J Clin Endocrinol Metab; 2006 Apr; 91(4):1239-45. PubMed ID: 16403824
[TBL] [Abstract][Full Text] [Related]
46. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
[TBL] [Abstract][Full Text] [Related]
47. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
[TBL] [Abstract][Full Text] [Related]
48. A legendary sumo wrestler with gigantism or acromegaly? The case of Ikezuki Geitazaemon (1827-1850).
Takada K; Sasano M; Hayakawa S
Med Hypotheses; 2020 Nov; 144():110174. PubMed ID: 33254497
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
Freda PU; Post KD; Powell JS; Wardlaw SL
J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
[TBL] [Abstract][Full Text] [Related]
50. Octreotide as primary therapy for acromegaly.
Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
[TBL] [Abstract][Full Text] [Related]
51. Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance.
Colao A; Pivonello R; Auriemma RS; De Martino MC; Bidlingmaier M; Briganti F; Tortora F; Burman P; Kourides IA; Strasburger CJ; Lombardi G
Eur J Endocrinol; 2006 Mar; 154(3):467-77. PubMed ID: 16498061
[TBL] [Abstract][Full Text] [Related]
52. Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values?
Kohler S; Tschopp O; Sze L; Neidert M; Bernays RL; Spanaus KS; Wiesli P; Schmid C
Gen Comp Endocrinol; 2013 Jul; 188():282-7. PubMed ID: 23648743
[TBL] [Abstract][Full Text] [Related]
53. GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency.
Giavoli C; Profka E; Verrua E; Ronchi CL; Ferrante E; Bergamaschi S; Sala E; Malchiodi E; Lania AG; Arosio M; Ambrosi B; Spada A; Beck-Peccoz P
J Clin Endocrinol Metab; 2012 Nov; 97(11):3983-8. PubMed ID: 22904173
[TBL] [Abstract][Full Text] [Related]
54. Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels.
Freda PU; Nuruzzaman AT; Reyes CM; Sundeen RE; Post KD
J Clin Endocrinol Metab; 2004 Feb; 89(2):495-500. PubMed ID: 14764751
[TBL] [Abstract][Full Text] [Related]
55. Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy of hypertensive patients.
Sesti G; Sciacqua A; Scozzafava A; Vatrano M; Angotti E; Ruberto C; Santillo E; Parlato G; Perticone F
J Hypertens; 2007 Feb; 25(2):471-7. PubMed ID: 17211256
[TBL] [Abstract][Full Text] [Related]
56. GH response to oral glucose tolerance test: a comparison between patients with acromegaly and other pituitary disorders.
Verrua E; Filopanti M; Ronchi CL; Olgiati L; Ferrante E; Giavoli C; Sala E; Mantovani G; Arosio M; Beck-Peccoz P; Lania AG; Spada A
J Clin Endocrinol Metab; 2011 Jan; 96(1):E83-8. PubMed ID: 20962023
[TBL] [Abstract][Full Text] [Related]
57. Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center.
Barrande G; Pittino-Lungo M; Coste J; Ponvert D; Bertagna X; Luton JP; Bertherat J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3779-85. PubMed ID: 11061538
[TBL] [Abstract][Full Text] [Related]
58. [Acromegaly and pregnancy: report of six new cases].
Persechini ML; Gennero I; Grunenwald S; Vezzosi D; Bennet A; Caron P
J Gynecol Obstet Biol Reprod (Paris); 2014 Nov; 43(9):704-12. PubMed ID: 24035359
[TBL] [Abstract][Full Text] [Related]
59. The influence of age on the GH-IGF1 axis in patients with acromegaly.
Tanimoto K; Hizuka N; Fukuda I; Takano K; Hanafusa T
Eur J Endocrinol; 2008 Oct; 159(4):375-9. PubMed ID: 18653547
[TBL] [Abstract][Full Text] [Related]
60. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
Wiesli P; Zwimpfer C; Zapf J; Schmid C
Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
